Pre‐transplant and longitudinal changes in faecal microbiome characteristics are associated with subsequent development of chronic graft‐versus‐host disease
Open Access
- 8 August 2023
- journal article
- research article
- Published by Wiley in British Journal of Haematology
- Vol. 203 (2) , 288-294
Abstract
Summary: The role of the gastrointestinal microbiome in predisposing to chronic graft‐versus‐host disease (cGVHD), an immune‐mediated haematopoietic cell transplant (HCT) complication, is not well defined. We examined the relationship of the host faecal microbiome with subsequent cGVHD development by analysing baseline stool samples as well as post‐HCT changes in microbiome composition and metabolite pathway analyses. We analysed pre‐transplant baseline samples from 11 patients who subsequently developed cGVHD compared to 13 controls who did not develop acute GVHD or cGVHD at any time. We found a significant differential abundance of multiple taxa at baseline between cGVHD versus controls, including the Actinobacteria phylum and Clostridium genus. A subgroup analysis of longitudinal samples within each patient revealed a greater loss of alpha diversity from baseline to post‐engraftment in patients who subsequently developed cGVHD. Metabolic pathways analysis revealed that two pathways associated with short‐chain fatty acid metabolism were enriched in cGVHD patient microbiomes: β‐oxidation and acyl‐CoA synthesis, and γ‐aminobutyrate shunt. In contrast, a tryptophan catabolism pathway was enriched in controls. Our findings show a distinct pattern of baseline microbiome and metabolic capacity that may play a role in modulating alloreactivity in patients developing cGVHD. These findings support the therapeutic potential of microbiome manipulation for cGVHD prevention.Keywords
This publication has 28 references indexed in Scilit:
- Gut Microbiota Predict Pulmonary Infiltrates after Allogeneic Hematopoietic Cell TransplantationAmerican Journal of Respiratory and Critical Care Medicine, 2016
- Intestinal Blautia Is Associated with Reduced Death from Graft-versus-Host DiseaseTransplantation and Cellular Therapy, 2015
- National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group ReportTransplantation and Cellular Therapy, 2015
- The effects of intestinal tract bacterial diversity on mortality following allogeneic hematopoietic stem cell transplantationBlood, 2014
- The microbial metabolite butyrate regulates intestinal macrophage function via histone deacetylase inhibitionProceedings of the National Academy of Sciences, 2014
- Discovery and validation of graft-versus-host disease biomarkersBlood, 2013
- Butyrate-producingClostridiumcluster XIVa species specifically colonize mucins in anin vitrogut modelThe ISME Journal, 2012
- Tryptophan catabolism is associated with acute GVHD after human allogeneic stem cell transplantation and indicates activation of indoleamine 2,3-dioxygenaseBlood, 2011
- Diversity of human colonic butyrate‐producing bacteria revealed by analysis of the butyryl‐CoA:acetate CoA‐transferase geneEnvironmental Microbiology, 2010
- Inhibition of histone-deacetylase activity by short-chain fatty acids and some polyphenol metabolites formed in the colonThe Journal of Nutritional Biochemistry, 2008